Skip to main content
. 2022 Jun 11;14(6):1238. doi: 10.3390/pharmaceutics14061238

Table 4.

Effect of pH and chitosan type on PspA4Pro adsorption and encapsulation into PGA-co-PDL and PLGA hybrid NPs prepared by single (o/w) or double (w/o/w) emulsion solvent evaporation method (mean ± SD, n = 3).

PGA-co-PDL PLGA
Formulation PspA (µg)/NP (mg) %LE * PspA (µg)/NP (mg) %LE *
Adsorption without chitosan pH 7.0 25.57 ± 8.13 63.94 ± 20.33 8.24 ± 6.28 20.60 ± 15.7
without chitosan pH 4.0 9.31 ± 4.34 23.26 ± 10.85 36.28 ± 0.23 90.69 ± 0.57
HCl-CS pH 7.0 36.49 ± 1.15 91.23 ± 2.87 37.59 ± 1.94 93.97 ± 4.84
CM-CS pH 7.0 15.41 ± 2.48 38.52 ± 6.21 10.55 ± 5.10 26.40 ± 12.62
CM-CS pH 4.0 11.39 ± 4.13 28.49 ± 10.33 29.62 ± 7.80 74.04 ± 19.48
Encapsulation without chitosan pH 7.0 4.14 ± 0.22 2.07 ± 0.80 29.57 ± 4.9 14.78 ± 7.36
HCl-CS pH 7.0 22.88 ± 2.65 11.44 ± 6.62 59.33 ± 1.32 29.66 ± 4.65
CM-CS pH 7.0 7.86 ± 1.83 3.93 ± 6.71 11.88 ± 4.15 5.94 ± 1.7

* %LE = load efficiency.